Logo

ONMD

OneMedNet Corporation

ONMD

OneMedNet Corporation • NASDAQ
$1.77 ▲ 25.00% (+0.35)
Market Cap $58.19 M
52w High $4.22
52w Low $0.30
Dividend Yield 0%
P/E -29.58
Volume 33.15M
Outstanding Shares 32.79M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $177K ▲ $2.003M ▲ $-741K ▼ -418.644% ▼ $-0.02 ▼ $-725K ▼
Q2-2025 $155K ▲ $1.822M ▼ $2.982M ▲ 1.924K% ▲ $0.081 ▲ $3.038M ▲
Q1-2025 $137K ▲ $2M ▼ $-1.902M ▲ -1.388K% ▲ $-0.056 ▲ $-1.859M ▲
Q4-2024 $26K ▼ $2.614M ▲ $-2.374M ▼ -9.131K% ▼ $-0.085 ▼ $-2.319M ▼
Q3-2024 $142K $2.303M $-2.058M -1.449K% $-0.074 $-2.012M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $149K ▼ $1.506M ▼ $5.445M ▼ $-3.939M ▼
Q2-2025 $1.72M ▲ $2.337M ▲ $6.177M ▼ $-3.84M ▲
Q1-2025 $937K ▼ $1.732M ▼ $18.282M ▼ $-16.55M ▼
Q4-2024 $3.021M ▼ $3.727M ▼ $19.677M ▲ $-15.95M ▼
Q3-2024 $4.09M $4.388M $18.656M $-14.268M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-741K ▼ $-1.558M ▲ $1.108M ▲ $477K ▼ $27K ▲ $-1.558M ▲
Q2-2025 $2.982M ▲ $-2.284M ▼ $-670K ▼ $2.932M ▲ $-22K ▲ $-2.287M ▼
Q1-2025 $-1.902M ▲ $-1.948M ▲ $1.92M ▲ $0 ▲ $-28K ▲ $-1.953M ▲
Q4-2024 $-2.374M ▼ $-2.027M ▼ $365K ▲ $-100K ▼ $-1.762M ▼ $-2.062M ▼
Q3-2024 $-2.057M $-1.903M $-2.34M $5.47M $1.227M $-1.912M

Revenue by Products

Product Q2-2024Q3-2024Q4-2024Q2-2025
Subscription Revenue
Subscription Revenue
 $0 ▲$0 ▲$0 ▲$0 ▲

Five-Year Company Overview

Income Statement

Income Statement OneMedNet is still essentially a pre‑revenue business based on the data shown, with no meaningful sales yet and ongoing operating losses. The company appears to be spending ahead of revenue to build its data platform and network. Losses have been persistent over several years, and earnings per share have been volatile, likely reflecting SPAC‑related accounting and small absolute scale rather than business maturity. Overall, this is a very early-stage income statement: low or no revenue, negative margins, and a clear need to prove that the technology can translate into steady commercial demand.

Balance Sheet

Balance Sheet The reported balance sheet looks extremely thin, with minimal assets, effectively no reported cash in this snapshot, small amounts of debt, and negative equity. That combination typically signals a fragile financial position and reliance on external funding to operate. The mention of recent capital raises and liability reductions suggests active balance sheet repair, but the numbers remain tight. In practical terms, there is little buffer to absorb setbacks, so access to capital and balance sheet strengthening are critical watch points.

Cash Flow

Cash Flow Cash flow from operations has been consistently negative, which is typical for a young, pre‑revenue tech platform but still important: the business is consuming cash rather than generating it. Capital spending appears very light, consistent with an asset‑light, software‑driven model, but that does not offset the fact that the company depends on financing to cover its burn. Future health will hinge on two things: whether operating cash outflows begin to narrow as revenue appears, and whether the company can maintain adequate funding while that transition plays out.

Competitive Edge

Competitive Edge Competitively, OneMedNet occupies a specialized niche: regulatory‑grade imaging real‑world data for life sciences. Its main strengths are a large and growing network of healthcare providers, deep imaging datasets, and a focus on data that can support regulatory use, not just research. The integration with Palantir’s platform adds credibility and usability for customers, particularly around advanced search and AI‑driven analysis. However, it operates in a competitive and fast‑moving space, with other imaging and data platforms vying for attention. As a smaller player, its position depends on expanding its network, converting pilots into recurring contracts, and maintaining trust with both hospitals and life sciences clients.

Innovation and R&D

Innovation and R&D Innovation is the clear centerpiece of the story. The company’s iRWD platform, combined with AI‑based de‑identification and curation, aims to turn complex imaging archives into usable, compliant datasets for drug and device development. The partnership with Palantir, use of natural‑language and AI tools for data discovery, and focus on subscription‑ready workflows all point to an aggressive push to move up the value chain from raw data to high‑value, curated solutions. The same strengths also bring execution risk: the firm must keep pace technologically, demonstrate clear ROI to customers, and scale its offerings while controlling costs. In effect, it behaves much more like an early‑stage R&D and product‑development company than a mature data vendor.

Summary

OneMedNet combines an ambitious technology and data story with very early‑stage, weak reported financials. On the positive side, it targets a promising niche—regulatory‑grade medical imaging data—backed by proprietary tech, a sizable provider network, and a high‑profile partnership with Palantir. The strategy emphasizes recurring, subscription‑like revenue from a differentiated data platform. On the risk side, the company is still pre‑revenue in the disclosed figures, consistently loss‑making, and operating with a thin balance sheet and ongoing cash burn. The key questions going forward are whether it can convert its innovation and network into durable, growing revenue; strengthen its financial foundation; and sustain its technological lead in a competitive, capital‑intensive space.

NEWS

November 24, 2025 · 8:55 AM UTC

OneMedNet to Showcase Transformative New Platform at RSNA 2025

Read more

November 20, 2025 · 9:00 AM UTC

OneMedNet Accelerates Subscription Revenue Strategy with Industry-Leading Network Expansion: Clinical Exams Increase 37%, Patient Records Grow 38%

Read more

November 17, 2025 · 7:45 AM UTC

OneMedNet Reports 815% Bookings Increase and 4.5X increase in Inbound Demand

Read more

November 10, 2025 · 7:30 AM UTC

OneMedNet Delivers on Revenue Model Promise with Palantir-Powered RWD Subscriptions: Live Feeds & AI Search

Read more

October 20, 2025 · 8:45 AM UTC

OneMedNet Welcomes Our Latest Subscriber mlHealth360

Read more